Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"WHO International Clinical Trials Registry Platform"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Psychiatry%22&type=Subject&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22
/vufind/Search/Results?lookfor=%22Psychiatry%22&type=Subject&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22
Search /vufind/Search2/Results?lookfor=%22Psychiatry%22&type=Subject&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22
PubPharm (3.454)
1
Randomised, double-blind, placebo-controlled trial evaluating the effects of naltrexone hydrochloride nasal spray on alcohol consumption in Alcohol Use Disorder : Randomised, double-blind, placebo-controlled trial evaluating the effects of naltrexone hydrochloride nasal spray on alcohol consumption in Alcohol Use Disorder - Effects of intranasal naltrexone on Alcohol Use Disorder
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
The use of Oxytocin for Autism Spectrum Disorders: Investigating theeffect on behavior and at the level of the brain. : Oxytocin-based pharmacotherapy for Autism Spectrum Disorders:Investigating the neural and behavioral effects of a promising interventionapproach - Oxytocin study
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
Add-on to antipsychotics in the treatment of schizophrenia : A randomized, double-blind, placebo controlled study to evaluate the efficacy and safety of Naproxen, Simvastatin and their combination, compared to placebo as add-on to anti-psychotics in the treatment of patients with schizophrenia and schizoaffective disorder. - NAS-S-01
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
4
A Study of the Efficacy and Safety of Intranasal Esketamine in the Rapid Reduction of Symptoms of Major Depressive Disorder, in Adults at Imminent Risk for Suicide : A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to be at Imminent Risk for Suicide
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
5
A Phase 4 study to Assess the Safety and Efficacy of Guanfacine Hydrochloride Prolonged release (SPD503) in Children and Adolescents aged 6 to 17 Years with ADHD : A Phase 4, Multicenter, 2-part Study Composed of a 1-Year Randomized, Double-blind, Parallel-group, Placebo-controlled, Active-comparator, Dose-optimization Evaluation followed by a 1-Year Open-label Evaluation to Assess the Safety and Efficacy of Guanfacine HydrochlorideProlonged-release (SPD503) in Children and Adolescents aged 6 to 17 Yearswith Attention-deficit/Hyperactivity Disorder - SPD503-401 League
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
6
Randomised, double-blind, placebo-controlled trial evaluating the effects of naltrexone hydrochloride nasal spray on alcohol consumption in Alcohol Use Disorder : Randomised, double-blind, placebo-controlled trial evaluating the effects of naltrexone hydrochloride nasal spray on alcohol consumption in Alcohol Use Disorder - Effects of intranasal naltrexone on alcohol use disorder
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
7
Open-label Trial of Brexpiprazole in the Treatment of Borderline Personality Disorder : A Multicenter, Open-label Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Adult Subjects With Borderline Personality Disorder
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
8
Simvastatin add-on to Escitalopram in patients with obesity and depression : Simvastatin add-on to Escitalopram in patients with comorbid obesity and major depression: A multicenter, randomized, double-blind, placebo-controlled trial
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
9
Multicentre trial in to investigate the usage of antidepressant and antipsychotics (with / without approval) in patients at the age of children and adolescents : Pharmacovigilance in children and adolescents: clinical trial protocol, subproject 1:Large Simple Trial, IIIb on the (off-label-) use of antidepressants and antipsychotics - TDM-VIGIL
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
10
A randomised study to evaluate Lurasidone versus Placebo in improving cognitive functioning in patients with Bipolar Disorder : A 6-Week Randomised, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy of Lurasidone Adjunctive Therapy in Improving Cognitive Functioning in Euthymic Bipolar Disorder Patients (ELICE-BD) - ELICE-BD
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[346]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Zeitschrift: WHO International Clinical Trials Registry Platform
Medienart
3.454
Aufsätze
3.454
E-Artikel
3.454
E-Ressourcen
Zeitschriftentitel
WHO International Clinical Trials Registry Plat...
Thema
3.454
610
3.430
Study Type: Interventional
2.366
Recruitment Status: Not yet recruiting
1.160
Phase: Phase 3
868
Recruitment Status: Authorised-recruitment may ...
672
Phase: Phase 2
400
Phase: Phase 4
90
Medical Condition: Schizophrenia MedDRA version...
72
Medical Condition: Schizophrenia MedDRA version...
52
Recruitment Status: Completed
50
Medical Condition: Major Depressive Disorder;Th...
42
Medical Condition: Treatment-Resistant Major De...
34
Medical Condition: Treatment-resistant Major De...
32
Phase: Phase 1
30
Medical Condition: Autism Spectrum Disorder (AS...
26
Medical Condition: Major Depressive Disorder Me...
26
Medical Condition: Tics associated with Tourett...
24
Medical Condition: Schizophrenia MedDRA version...
22
Medical Condition: Major Depressive Disorder Me...
22
Medical Condition: schizophrenia with persisten...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
1.256
2020-
2.198
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
3.394
Englisch
44
Unbestimmt
4
Spanisch
2
Dänisch
2
Niederländisch
2
Französisch
2
Deutsch
2
Hausa
2
Norwegisch
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...